The two faces of IL-6 on Th1/Th2 differentiation

被引:728
作者
Diehl, S [1 ]
Rincón, M [1 ]
机构
[1] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA
关键词
Th1/Th2; differentiation; interleukin; cytokine signaling;
D O I
10.1016/S0161-5890(02)00210-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin (IL)-6 is a cytokine produced by several cell types including antigen presenting cells (APC) such as macrophages, dendritic cells, and B cells. IL-6 is involved in the acute phase response, B cell maturation, and macrophage differentiation. Here, we discuss a novel function of IL-6: the control of T helper (Th) 1/Th2 differentiation. IL-6 promotes Th2 differentiation and simultaneously inhibits Th1 polarization through two independent molecular mechanisms. IL-6 activates transcription mediated by nuclear factor of activated T cells (NFAT) leading to production of IL-4 by naive CD4(+) T cells and their differentiation into effector Th2 cells. While the induction of Th2 differentiation by IL-6 is dependent upon endogenous IL-4, inhibition of Th1 differentiation by IL-6 is IL-4- and NFAT- independent. IL-6 inhibits Th1 differentiation by upregulating supressor of cytokine signaling (SOCS)-1 expression to interfere with IFNgamma signaling and the development of Th1 cells. Since IL-6 is abundantly produced by APC, it is a likely source of early Th1/Th2 control during CD4(+) T cell activation. Thus, by using two independent molecular mechanisms, IL-6 plays a dual role in Th1/Th2 differentiation. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 45 条
[1]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[2]   MOLECULAR-CLONING OF APRF, A NOVEL IFN-STIMULATED GENE FACTOR-3 P91-RELATED TRANSCRIPTION FACTOR INVOLVED IN THE GP130-MEDIATED SIGNALING PATHWAY [J].
AKIRA, S ;
NISHIO, Y ;
INOUE, M ;
WANG, XJ ;
WEI, S ;
MATSUSAKA, T ;
YOSHIDA, K ;
SUDO, T ;
NARUTO, M ;
KISHIMOTO, T .
CELL, 1994, 77 (01) :63-71
[3]   Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction [J].
Alexander, WS ;
Starr, R ;
Metcalf, D ;
Nicholson, SE ;
Farley, A ;
Elefanty, AG ;
Brysha, M ;
Kile, BT ;
Richardson, R ;
Baca, M ;
Zhang, JG ;
Willson, TA ;
Viney, EM ;
Sprigg, NS ;
Rakar, S ;
Corbin, J ;
Mifsud, S ;
DiRago, L ;
Cary, D ;
Nicola, NA ;
Hilton, DJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (04) :588-592
[4]   SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine [J].
Alexander, WS ;
Starr, R ;
Fenner, JE ;
Scott, GL ;
Handman, E ;
Sprigg, NS ;
Corbin, JE ;
Cornish, AL ;
Darwiche, R ;
Owczarek, CM ;
Kay, TWH ;
Nicola, NA ;
Hertzog, PJ ;
Metcalf, D ;
Hilton, DJ .
CELL, 1999, 98 (05) :597-608
[5]   Effect of anti-interleukin 12 treatment on murine lyme borreliosis [J].
Anguita, J ;
Persing, DH ;
Rincon, M ;
Barthold, SW ;
Fikrig, E .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :1028-1034
[6]   Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis [J].
Anguita, J ;
Rincón, M ;
Samanta, S ;
Barthold, SW ;
Flavell, RA ;
Fikrig, E .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05) :1512-1515
[7]   The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].
Bach, EA ;
Aguet, M ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&
[8]  
Bradley LM, 1996, J IMMUNOL, V157, P1350
[9]   Neutralization of interferon-γ in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease [J].
Bullen, DVR ;
Darwiche, R ;
Metcalf, D ;
Handman, E ;
Alexander, WS .
IMMUNOLOGY, 2001, 104 (01) :92-98
[10]  
Chow CW, 1999, MOL CELL BIOL, V19, P2300